These results suggest that MAIT cell deficiency may contribute to the impaired immunity in MM patients, and moreover, that manipulation of the MR1-Ag-MAIT cell axis may provide a novel avenue for immunotherapy in MM and other haematological malignancies. The gene discussed is RENBP; the disease is Miyoshi myopathy.